In addition to modulating the transcriptional activity of several nuclear receptors, CBP and p300 act as integrators of various cellular signaling pathways, including the WNT/β-catenin signaling pathway that is involved in cell proliferation and tumor development [135]. Here, EP300 is linked to neoplasm.